PDB11 LONG-TERM COST-EFFECTIVENESS ANALYSIS OF REPAGLINIDE VERSUS NATEGLINIDE IN COMBINATION WITH METFORMIN IN TYPE 2 DIABETES PATIENTS FAILING MONOTHERAPY IN THE SWEDISH SETTING
Abstract
Authors
J Ray AS Brandt V Foos V Munro WJ Valentine S Roze AJ Palmer